A widely sought-after weight loss treatment aided pharma company Novo Nordisk to achieve stratospheric success by surpassing the market value of the entire Danish economy.
With its latest expansion of the drug into the U.K., Novo now has become Europe’s most valuable company, dethroning French luxury brand LVMH, which has held the title since 2021.
